| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00637740 |
| P8608 | Fatcat ID | release_4kswcglr4vgdza3epbh2c6xsk4 |
| P698 | PubMed publication ID | 2776817 |
| P2093 | author name string | A Wallin | |
| A Nergårdh | |||
| P A Hynning | |||
| P2860 | cites work | Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages | Q36634164 |
| Maternal, fetal, and neonatal lidocaine levels following local perineal infiltration | Q39554058 | ||
| Lidocaine toxicity from topical mucosal application. With a review of the clinical pharmacology of lidocaine | Q40268688 | ||
| Maternal, fetal, and neonatal metabolism of lidocaine | Q41677064 | ||
| Prolonged seizures associated with the use of viscous lidocaine | Q42264587 | ||
| Seizures induced by oral viscous lidocaine | Q42579574 | ||
| Age-dependent lidocaine disposition in patients with acute myocardial infarction. | Q51828762 | ||
| Protein binding and disposition of lignocaine in the elderly. | Q51832037 | ||
| Plasma lignocaine concentrations following topical laryngeal application. | Q51855655 | ||
| Influence of long-term infusions on lidocaine kinetics. | Q51862023 | ||
| Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide | Q52114688 | ||
| The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine. | Q52705819 | ||
| The convulsant potency of lidocaine and its N-dealkylated metabolites | Q52729244 | ||
| P433 | issue | 6 | |
| P921 | main subject | lidocaine | Q216935 |
| seizure | Q6279182 | ||
| P304 | page(s) | 583-586 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Lidocaine treatment of neonatal convulsions, a therapeutic dilemma. | |
| P478 | volume | 36 |
| Q38057226 | A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. |
| Q35862257 | Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment. |
| Q35754082 | Lidocaine for Status Epilepticus in Pediatrics. |
| Q51698844 | Lidocaine for treatment of severe seizures in newborn infants. II. Blood concentrations of lidocaine and metabolites during intravenous infusion. |
| Q58923727 | Neonatal Seizures |
| Q74426799 | Neonatal seizures |
| Q43850519 | Pervasive seizures caused by hypoxic-ischemic encephalopathy: treatment with intravenous paraldehyde |
Search more.